Table 2.
Basic characteristics at 20 years after kidney transplantation
| All KTRs, | KTRs with cancer, | KTRs without cancer, | ||
|---|---|---|---|---|
| n = 293 | n = 74 | n = 219 | P-value | |
| Immunosuppression, n (%) | ||||
| Calcineurin-inhibitor | ||||
| Ciclosporin | 235 (80) | 58 (78) | 177 (81) | 0.736 |
| Tacrolimus | 45 (15) | 12 (16) | 33 (15) | 0.853 |
| Antimetabolite | ||||
| MMF/MPA | 158 (54) | 40 (54) | 118 (54) | 1 |
| Azathioprine | 113 (39) | 30 (41) | 83 (38) | 0.681 |
| Steroid | 100 (34) | 36 (49) | 73 (33) | 0.132 |
| Other medication | ||||
| Acetylsalicylic acid, n (%) | 81 (28) | 21 (28) | 60 (27) | 0.886 |
| Proton pump inhibitors, n (%) | 71 (24) | 16 (22) | 55 (25) | 0.759 |
| Statin, n (%) | 162 (55) | 40 (54) | 122 (56) | 0.911 |
| Antihypertensives, n (%) | ||||
| 0 | 58 (20) | 19 (26) | 39 (19) | 0.176 |
| 1 | 93 (32) | 19 (26) | 74 (34) | 0.404 |
| 2 | 96 (33) | 22 (30) | 74 (34) | 0.685 |
| >2 | 46 (16) | 14 (19) | 32 (15) | 0.472 |
| Diuretics, n (%) | ||||
| Thiazide diuretics | 24 (8) | 9 (12) | 15 (7) | 0.150 |
| Loop diuretics | 60 (20) | 21 (28) | 39 (18) | 0.150 |
| Smoking, n (%) | 43 (15) | 14 (19) | 19 (9) | 0.040* |
| Diabetes mellitus, n (%) | 61 (21) | 20 (27) | 41 (19) | 0.264 |
| Insulin therapy, n (%) | 24 (8) | 8 (11) | 16 (7) | 0.466 |